Higher Polygenic Risk Scores for Schizophrenia May Be Suggestive of Treatment Non-Response in Major Depressive Disorder

doi 10.1101/2020.01.15.20017699
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Polygenic Risk Scores for Major Depressive Disorder and Neuroticism as Predictors of Antidepressant Response: Meta-Analysis of Three Treatment Cohorts

PLoS ONE
Multidisciplinary
2018English

Polygenic Risk Scores in Clinical Schizophrenia Research

American Journal of Psychiatry
PsychiatryMental Health
2019English

Polygenic Risk Scores and Bipolar Disorder

Journal of Psychiatry and Brain Science
2018English

Use of Schizophrenia and Bipolar Disorder Polygenic Risk Scores to Identify Psychotic Disorders

British Journal of Psychiatry
MedicinePsychiatryMental Health
2018English

Applying Polygenic Risk Scoring for Psychiatric Disorders to a Large Family With Bipolar Disorder and Major Depressive Disorder

Communications Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgricultural
2018English

Evaluation of Factors Affecting Treatment Response and Risk Factors for Patients Diagnosed With Non-Psychotic Major Depressive Disorder: A Literature Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Polygenic Risk Scores, School Achievement and Risk for Schizophrenia: A Danish Population-Based Study

Biological Psychiatry
Biological Psychiatry
2018English

Gene Expression Biomarkers of Response to Citalopram Treatment in Major Depressive Disorder

Translational Psychiatry
PsychiatryMolecular NeuroscienceBiological PsychiatryMental HealthCellular
2011English

Duloxetine in the Treatment of Major Depressive Disorder

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy